Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-12 @ 6:02 AM
Study NCT ID:
NCT06937905
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-22
First Post:
2025-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-14
First Submit QC Date:
None
Study First Post Date:
2025-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-14
Last Update Post Date:
2025-04-22
Last Update Post Date Type:
ACTUAL